SCHEMBL4841214

SCHEMBL4841214

CN1C(=O)[C@@H](N)CC=C[C@@H]1c1ccccc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.38
KMT2A Q03164 1/20 0.38
LMNA P02545 1/20 0.36
ADORA3 P0DMS8 1/20 0.36
BRD4 O60885 3/20 0.35
HDAC4 P56524 1/20 0.35
SRD5A1 P18405 1/20 0.33
ALDH1A1 P00352 3/20 0.33
GFER P55789 1/20 0.33
MAPT P10636 2/20 0.32
KDM4E B2RXH2 1/20 0.32
GAA P10253 1/20 0.32
HPGD P15428 1/20 0.32
HSD17B2 P37059 2/20 0.32
GABRP O00591 1/20 0.32
GABRD O14764 1/20 0.32
GABRA1 P14867 1/20 0.32
GABRB1 P18505 1/20 0.32
GABRG2 P18507 1/20 0.32
GABRB3 P28472 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4841772 1.00 TSHR (0.38) TSHRKMT2ALMNAADORA3BRD4
SCHEMBL4841551 0.78 ALDH1A1 (0.38) TSHRKMT2ALMNAALDH1A1MAPT
SCHEMBL4841082 0.78 ALDH1A1 (0.38) TSHRKMT2ALMNAALDH1A1MAPT
SCHEMBL5795559 0.78 ALDH1A1 (0.38) TSHRKMT2ALMNAALDH1A1MAPT
SCHEMBL4845496 0.77 MEN1 (0.36) TSHRKMT2ALMNAADORA3ALDH1A1
SCHEMBL5792149 0.77 MEN1 (0.36) TSHRKMT2ALMNAADORA3ALDH1A1
SCHEMBL4839870 0.77 ALDH1A1 (0.44) TSHRKMT2AALDH1A1MAPT
SCHEMBL5791168 0.77 NPSR1 (0.43) KMT2ALMNAALDH1A1GAA
SCHEMBL5791105 0.77 ALDH1A1 (0.44) TSHRKMT2AALDH1A1MAPT
SCHEMBL4833881 0.77 NPSR1 (0.43) KMT2ALMNAALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7342007-B2 Lactams and uses thereof ASTRAZENECA AB (SE) 2008-03-11 US disclosed
US-7342007-B2 Lactams and uses thereof ASTRAZENECA AB (SE) 2008-03-11 US disclosed
US-7342007-B2 Lactams and uses thereof ASTRAZENECA AB (SE) 2008-03-11 US disclosed
US-20060183732-A1 Novel lactams and uses thereof ASTRAZENECA AB (SE) 2006-08-17 US disclosed
WO-2004080983-A1 NOVEL LACTAMS AND USES THEREOF ASTRAZENECA AB (SE) 2004-09-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060183732-A1 Novel lactams and uses thereof BACE1, BACE2, APP TSHR 4818/4885KMT2A 4366/4885LMNA 2273/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.